SNCA and Parkinson disease: Administration of GM1 alone was shown to activate autophagy in vitro and in vivo, resulting in increased clearance of α-synuclein in PD cells (Guo et al., 2020) and decreased apoptosis in AD models (Dai et al., 2017).